Recent Finacing
Recent Raise
Ocunova is a Penn State spinout developing OCU-001, a rapid-acting ophthalmic therapy targeting underlying causes of diabetic dry eye syndrome and advancing it through preclinical and clinical trials.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at Life Sciences Greenhouse of Pennsylvania.